Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock.

[1]  D. Paterson,et al.  The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  T. Dellit,et al.  Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureus bacteremia. , 2011, Diagnostic microbiology and infectious disease.

[3]  A. Forrest,et al.  Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization , 2011, Antimicrobial Agents and Chemotherapy.

[4]  Marlea G. Wellein,et al.  Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial , 2011, Antimicrobial Agents and Chemotherapy.

[5]  A. Raglio,et al.  Clinical Impact of Antimicrobial Resistance in European Hospitals: Excess Mortality and Length of Hospital Stay Related to Methicillin-Resistant Staphylococcus aureus Bloodstream Infections , 2011, Antimicrobial Agents and Chemotherapy.

[6]  K. Bowker,et al.  Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[7]  R. Kullar,et al.  Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  J. Vincent,et al.  Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens , 2011, Antimicrobial Agents and Chemotherapy.

[9]  R. Hall,et al.  Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? , 2010, The American journal of medicine.

[10]  V. Tam,et al.  Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy. , 2009, International journal of antimicrobial agents.

[11]  Anand Kumar,et al.  Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. , 2009, Chest.

[12]  G. Drusano,et al.  Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Ronald N. Jones,et al.  Nine-Hospital Study Comparing Broth Microdilution and Etest Method Results for Vancomycin and Daptomycin against Methicillin-Resistant Staphylococcus aureus , 2009, Antimicrobial Agents and Chemotherapy.

[14]  J. Roberts,et al.  Pharmacokinetic issues for antibiotics in the critically ill patient , 2009, Critical care medicine.

[15]  P. Viale,et al.  Prospectively Validated Dosing Nomograms for Maximizing the Pharmacodynamics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients , 2009, Antimicrobial Agents and Chemotherapy.

[16]  Michael R. Mulvey,et al.  Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006 , 2008, Antimicrobial Agents and Chemotherapy.

[17]  A. Wong-Beringer,et al.  High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. , 2006, Archives of internal medicine.

[18]  N. V. Jiménez-Torres,et al.  Population pharmacokinetic parameters of vancomycin in critically ill patients , 2006, Journal of clinical pharmacy and therapeutics.

[19]  Joshua A. Doherty,et al.  Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. , 2006, Chest.

[20]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[21]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[22]  P Wright,et al.  Changing pattern of organ dysfunction in early human sepsis is related to mortality , 2000, Critical care medicine.

[23]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[24]  E. Anderson.  Hudson et al. , 1977 .

[25]  C. Kirkpatrick,et al.  Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study. , 2012, International journal of antimicrobial agents.

[26]  S. Fridkin,et al.  IDSA GUIDELINES Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children , 2011 .

[27]  D. Levine,et al.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[28]  P. Viale,et al.  Antimicrobial Therapy in Critically Ill Patients , 2005, Clinical pharmacokinetics.

[29]  Jerome J. Schentag,et al.  Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections , 2004, Clinical pharmacokinetics.

[30]  S. Cosgrove,et al.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .